Article Versions Notes

Zhang X, Ishibashi M, Kitatani K, Shigeta S, Tokunaga H, Toyoshima M, Shimada M, Yaegashi N. Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer. Cancers. 2020; 12(6):1705. https://doi.org/10.3390/cancers12061705

Zhang, Xuewei, Masumi Ishibashi, Kazuyuki Kitatani, Shogo Shigeta, Hideki Tokunaga, Masafumi Toyoshima, Muneaki Shimada, and Nobuo Yaegashi. 2020. "Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer" Cancers 12, no. 6: 1705. https://doi.org/10.3390/cancers12061705

Zhang, X., Ishibashi, M., Kitatani, K., Shigeta, S., Tokunaga, H., Toyoshima, M., Shimada, M., & Yaegashi, N. (2020). Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer. Cancers, 12(6), 1705. https://doi.org/10.3390/cancers12061705